-
1
-
-
79953290820
-
50 years of research and discovery in chronic kidney disease and mineral & bone disorder: The central role of phosphate
-
Slatopolsky E, Moe S. 50 years of research and discovery in chronic kidney disease and mineral & bone disorder: The central role of phosphate. Kidney Int Suppl 2011; 121: S1-S2
-
(2011)
Kidney Int Suppl
, vol.121
, pp. S1-S2
-
-
Slatopolsky, E.1
Moe, S.2
-
2
-
-
68949114585
-
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
-
Moe SM, Drueke TB, Block G et al. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 76: S1-130
-
(2009)
Kidney Int Suppl
, vol.76
, pp. S1-S130
-
-
Moe, S.M.1
Drueke, T.B.2
Block, G.3
-
3
-
-
79957830094
-
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
-
Floege J, Kim J, Ireland E et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011; 26: 1948-1955
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 1948-1955
-
-
Floege, J.1
Kim, J.2
Ireland, E.3
-
4
-
-
79958133805
-
Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study
-
Naves-Diaz M, Passlick-Deetjen J, GuinsburgAet al. Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study. Nephrol Dial Transplant 2011; 26: 1938-1947
-
(2011)
Nephrol Dial Transplant
, vol.26
, pp. 1938-1947
-
-
Naves-Diaz, M.1
Passlick-Deetjen, J.2
Guinsburg, A.3
-
5
-
-
59949083708
-
Phosphorus and survival: Key questions that need answers
-
Cannata-Andia JB, Naves-Diaz M. Phosphorus and survival: key questions that need answers. J Am Soc Nephrol 2009; 20: 234-236
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 234-236
-
-
Cannata-Andia, J.B.1
Naves-Diaz, M.2
-
6
-
-
80053502175
-
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition
-
Zoccali C, Ruggenenti P, Perna A et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol 2011; 22: 1923-1930
-
(2011)
J Am Soc Nephrol
, vol.22
, pp. 1923-1930
-
-
Zoccali, C.1
Ruggenenti, P.2
Perna, A.3
-
7
-
-
79952604526
-
Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis
-
Palmer SC, Hayen A, Macaskill P et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis. JAMA 2011; 305: 1119-1127
-
(2011)
JAMA
, vol.305
, pp. 1119-1127
-
-
Palmer, S.C.1
Hayen, A.2
Macaskill, P.3
-
8
-
-
53749101804
-
Serum phosphate levels and risk of infection in incident dialysis patients
-
Plantinga LC, Fink NE, MelamedML et al. Serum phosphate levels and risk of infection in incident dialysis patients. Clin J Am Soc Nephrol 2008; 3: 1398-1406
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 1398-1406
-
-
Plantinga, L.C.1
Fink, N.E.2
Melamed, M.L.3
-
9
-
-
0035818258
-
Vascular calcification in chronic renal failure
-
Goodman WG. Vascular calcification in chronic renal failure. Lancet 2001; 358: 1115-1116
-
(2001)
Lancet
, vol.358
, pp. 1115-1116
-
-
Goodman, W.G.1
-
10
-
-
72049126357
-
High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression
-
Roman-Garcia P, Carrillo-Lopez N, Fernandez-Martin JL et al. High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. Bone 2010; 46: 121-128
-
(2010)
Bone
, vol.46
, pp. 121-128
-
-
Roman-Garcia, P.1
Carrillo-Lopez, N.2
Fernandez-Martin, J.L.3
-
11
-
-
79953281956
-
Cardiovascular risk factors in chronic kidney disease: Does phosphate qualify?
-
Hruska K, Mathew S, Lund R et al. Cardiovascular risk factors in chronic kidney disease: does phosphate qualify? Kidney Int 2011; 79 (suppl 121): S9-S13
-
(2011)
Kidney Int
, vol.79
, pp. S9-S13
-
-
Hruska, K.1
Mathew, S.2
Lund, R.3
-
12
-
-
33845916272
-
High dietary phosphate intake reduces bone strength in the growing rat skeleton
-
Huttunen MM, Tillman I, Viljakainen HTet al. High dietary phosphate intake reduces bone strength in the growing rat skeleton. J Bone Miner Res 2007; 22: 83-92
-
(2007)
J Bone Miner Res
, vol.22
, pp. 83-92
-
-
Huttunen, M.M.1
Tillman, I.2
Viljakainen, H.T.3
-
13
-
-
66149157312
-
Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function tomoderate kidney disease in MESA
-
Ix JH, De Boer IH, Peralta CA et al. Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function tomoderate kidney disease in MESA. Clin J Am Soc Nephrol 2009; 4: 609-615
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 609-615
-
-
Ix, J.H.1
De Boer, I.H.2
Peralta, C.A.3
-
14
-
-
84873410543
-
High phosphate directly affects endothelial function by downregulating annexin II
-
Di Marco GS, Konig M, Stock C et al. High phosphate directly affects endothelial function by downregulating annexin II. Kidney Int 2013; 83: 213-222
-
(2013)
Kidney Int
, vol.83
, pp. 213-222
-
-
Di Marco, G.S.1
Konig, M.2
Stock, C.3
-
15
-
-
59949091183
-
Serum phosphorus levels associate with coronary atherosclerosis in young adults
-
Foley RN, Collins AJ, Herzog CA et al. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 2009; 20: 397-404
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 397-404
-
-
Foley, R.N.1
Collins, A.J.2
Herzog, C.A.3
-
16
-
-
59949102335
-
Association of serum phosphate with vascular and valvular calcification in moderate CKD
-
Adeney KL, Siscovick DS, Ix JH et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 2009; 20: 381-387
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 381-387
-
-
Adeney, K.L.1
Siscovick, D.S.2
Ix, J.H.3
-
17
-
-
34248551943
-
Phosphorus comes of age as a cardiovascular risk factor
-
Foley RN. Phosphorus comes of age as a cardiovascular risk factor. Arch Intern Med 2007; 167: 873-874
-
(2007)
Arch Intern Med
, vol.167
, pp. 873-874
-
-
Foley, R.N.1
-
18
-
-
33845700085
-
Prevalence of abnormal serum Vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
-
Levin A, Bakris GL, MolitchMet al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38
-
(2007)
Kidney Int
, vol.71
, pp. 31-38
-
-
Levin, A.1
Bakris, G.L.2
Molitch, M.3
-
19
-
-
84877027844
-
Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease
-
Hill KM, Martin BR,Wastney ME et al. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int 2013; 83: 959-966
-
(2013)
Kidney Int
, vol.83
, pp. 959-966
-
-
Hill, K.M.1
Martin, B.R.2
Wastney, M.E.3
-
21
-
-
9644298257
-
Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro
-
Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 2004; 66: 2293-2299
-
(2004)
Kidney Int
, vol.66
, pp. 2293-2299
-
-
Yang, H.1
Curinga, G.2
Giachelli, C.M.3
-
22
-
-
84858038439
-
Mortality in kidney disease patients treated with phosphate binders: A randomized study
-
Di Iorio B, Bellasi A, Russo D. Mortality in kidney disease patients treated with phosphate binders: A randomized study. Clin J Am Soc Nephrol 2012; 7: 487-493
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 487-493
-
-
Di Iorio, B.1
Bellasi, A.2
Russo, D.3
-
24
-
-
84866366740
-
Update on fibroblast growth factor 23 in chronic kidney disease
-
Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int 2012; 82: 737-747
-
(2012)
Kidney Int
, vol.82
, pp. 737-747
-
-
Wolf, M.1
-
25
-
-
3543139492
-
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
-
Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2208-2218
-
-
Block, G.A.1
Klassen, P.S.2
Lazarus, J.M.3
-
26
-
-
9644276844
-
Vascular calcification mechanisms
-
Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-2964
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2959-2964
-
-
Giachelli, C.M.1
-
27
-
-
33646157733
-
Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification
-
Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006; 98: 905-912
-
(2006)
Circ Res
, vol.98
, pp. 905-912
-
-
Li, X.1
Yang, H.Y.2
Giachelli, C.M.3
-
29
-
-
0037835949
-
BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure
-
Davies MR, Lund RJ, Hruska KA. BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 2003; 14: 1559-1567
-
(2003)
J Am Soc Nephrol
, vol.14
, pp. 1559-1567
-
-
Davies, M.R.1
Lund, R.J.2
Hruska, K.A.3
-
30
-
-
33644849893
-
Vascular calcification and cardiovascular function in chronic kidney disease
-
SigristM, Bungay P, TaalMWet al. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 2006; 21: 707-714
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 707-714
-
-
Sigrist, M.1
Bungay, P.2
Taal, M.W.3
-
31
-
-
0037792116
-
Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease
-
Merjanian R, Budoff M, Adler S et al. Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal disease. Kidney Int 2003; 64: 263-271
-
(2003)
Kidney Int
, vol.64
, pp. 263-271
-
-
Merjanian, R.1
Budoff, M.2
Adler, S.3
-
32
-
-
77954090037
-
Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients
-
Nasrallah MM, El-Shehaby AR, Salem MM et al. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 2679-2685
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 2679-2685
-
-
Nasrallah, M.M.1
El-Shehaby, A.R.2
Salem, M.M.3
-
33
-
-
84893488379
-
Fibroblast growth factor-23 and cardiovascular events in CKD
-
Scialla JJ, Xie H, Rahman M et al. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol 2014; 25: 349-360
-
(2014)
J Am Soc Nephrol
, vol.25
, pp. 349-360
-
-
Scialla, J.J.1
Xie, H.2
Rahman, M.3
-
34
-
-
84888348838
-
Use of phosphate-binding agents is associated with a lower risk of mortality
-
Cannata-Andia JB, Fernandez-Martin JL, Locatelli F et al. Use of phosphate-binding agents is associated with a lower risk of mortality. Kidney Int 2013; 84: 998-1008
-
(2013)
Kidney Int
, vol.84
, pp. 998-1008
-
-
Cannata-Andia, J.B.1
Fernandez-Martin, J.L.2
Locatelli, F.3
-
35
-
-
84897839170
-
Cosmos: Abnormalities in the main bone andmineral biochemical parameters are associated with higher risk of mortality
-
Fernández-Martín J, London G, Gorriz JL et al. Cosmos: abnormalities in the main bone andmineral biochemical parameters are associated with higher risk of mortality. Nephrol Dial Transplant 2013; 28 (Suppl 1): i25-i26
-
(2013)
Nephrol Dial Transplant
, vol.28
, pp. i25-i26
-
-
Fernández-Martín, J.1
London, G.2
Gorriz, J.L.3
-
37
-
-
79951895648
-
Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease
-
Moe SM, Zidehsarai MP, Chambers MA et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 257-264
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 257-264
-
-
Moe, S.M.1
Zidehsarai, M.P.2
Chambers, M.A.3
-
38
-
-
84872246782
-
Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): Results of a randomized trial
-
SigristM, Tang M, BeaulieuMet al. Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial. Nephrol Dial Transplant 2013; 28: 161-169
-
(2013)
Nephrol Dial Transplant
, vol.28
, pp. 161-169
-
-
Sigrist, M.1
Tang, M.2
Beaulieu, M.3
-
39
-
-
84883243996
-
Phosphate homeostasis in CKD: Report of a scientific symposium sponsored by the National Kidney Foundation
-
Block GA, Ix JH, KettelerMet al. Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation. Am J Kidney Dis 2013; 62: 457-473
-
(2013)
Am J Kidney Dis
, vol.62
, pp. 457-473
-
-
Block, G.A.1
Ix, J.H.2
Ketteler, M.3
-
40
-
-
0036310682
-
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
-
Chertow GM, Burke SK, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252
-
(2002)
Kidney Int
, vol.62
, pp. 245-252
-
-
Chertow, G.M.1
Burke, S.K.2
Raggi, P.3
-
41
-
-
35349004713
-
Effects of sevelamer and calciumbased phosphate binders on mortality in hemodialysis patients
-
Suki WN, Zabaneh R, Cangiano JL et al. Effects of sevelamer and calciumbased phosphate binders on mortality in hemodialysis patients. Kidney Int 2007; 72: 1130-1137
-
(2007)
Kidney Int
, vol.72
, pp. 1130-1137
-
-
Suki, W.N.1
Zabaneh, R.2
Cangiano, J.L.3
-
42
-
-
33847223412
-
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients
-
Block GA, Raggi P, Bellasi A et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-441
-
(2007)
Kidney Int
, vol.71
, pp. 438-441
-
-
Block, G.A.1
Raggi, P.2
Bellasi, A.3
-
43
-
-
84884532581
-
Sevelamer versus calcium carbonate in incident hemodialysis patients: Results of an open-label 24-month randomized clinical trial
-
Di Iorio B, Molony D, Bell C et al. Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial. Am J Kidney Dis 2013; 62: 771-778
-
(2013)
Am J Kidney Dis
, vol.62
, pp. 771-778
-
-
Di Iorio, B.1
Molony, D.2
Bell, C.3
-
44
-
-
84901350961
-
REFOS study: Efficacy and safety of lanthanum carbonate in clinical practice in Spain
-
Torregrosa JV, Gonzalez-Parra E, GonzalezMTet al. REFOS study: efficacy and safety of lanthanum carbonate in clinical practice in Spain. Nefrologia 2014; 34: 360-368
-
(2014)
Nefrologia
, vol.34
, pp. 360-368
-
-
Torregrosa, J.V.1
Gonzalez-Parra, E.2
Gonzalez, M.T.3
-
45
-
-
79953033976
-
Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia
-
Shigematsu T, Tokumoto A, Nakaoka A et al. Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia. Ther Apher Dial 2011; 15: 176-184
-
(2011)
Ther Apher Dial
, vol.15
, pp. 176-184
-
-
Shigematsu, T.1
Tokumoto, A.2
Nakaoka, A.3
-
46
-
-
84887339745
-
Effect of calcium-based versus noncalcium-based phosphate binders on mortality in patients with chronic kidney disease: An updated systematic review and meta-analysis
-
Jamal SA, Vandermeer B, Raggi P et al. Effect of calcium-based versus noncalcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet 2013; 382: 1268-1277
-
(2013)
Lancet
, vol.382
, pp. 1268-1277
-
-
Jamal, S.A.1
Vandermeer, B.2
Raggi, P.3
-
47
-
-
78650315397
-
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: A controlled randomized study (CALMAG study) assessing efficacy and tolerability
-
de Francisco AL, Leidig M, Covic AC et al. Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: A controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 2010; 25: 3707-3717
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 3707-3717
-
-
De Francisco, A.L.1
Leidig, M.2
Covic, A.C.3
-
48
-
-
84884509947
-
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: Post hoc evaluation from a controlled, randomized study
-
Covic A, Passlick-Deetjen J, Kroczak M et al. A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study. Nephrol Dial Transplant 2013; 28: 2383-2392
-
(2013)
Nephrol Dial Transplant
, vol.28
, pp. 2383-2392
-
-
Covic, A.1
Passlick-Deetjen, J.2
Kroczak, M.3
-
49
-
-
84875035936
-
Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients
-
Wuthrich RP, Chonchol M, Covic A et al. Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients. Clin J AmSoc Nephrol 2013; 8: 280-289
-
(2013)
Clin J AmSoc Nephrol
, vol.8
, pp. 280-289
-
-
Wuthrich, R.P.1
Chonchol, M.2
Covic, A.3
-
50
-
-
84899827376
-
A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis
-
Yokoyama K, Akiba T, Fukagawa M et al. A randomized trial of JTT-751 versus sevelamer hydrochloride in patients on hemodialysis. Nephrol Dial Transplant 2013; 29: 1-10
-
(2013)
Nephrol Dial Transplant
, vol.29
, pp. 1-10
-
-
Yokoyama, K.1
Akiba, T.2
Fukagawa, M.3
-
51
-
-
84924004431
-
Ferric citrate controls phosphorus and delivers iron in patients on dialysis
-
Lewis JB, Sika M, Koury MJ et al. Ferric citrate controls phosphorus and delivers iron in patients on dialysis. J Am Soc Nephrol 2015; 26: 493-503
-
(2015)
J Am Soc Nephrol
, vol.26
, pp. 493-503
-
-
Lewis, J.B.1
Sika, M.2
Koury, M.J.3
-
52
-
-
84902250298
-
Coupling fibroblast growth factor 23 production and cleavage: Iron deficiency, rickets, and kidney disease
-
Wolf M, White KE. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease. Curr Opin Nephrol Hypertens 2014; 23: 411-419
-
(2014)
Curr Opin Nephrol Hypertens
, vol.23
, pp. 411-419
-
-
Wolf, M.1
White, K.E.2
-
53
-
-
37749016095
-
A comparative review of the efficacy and safety of established phosphate binders: Calcium, sevelamer, and lanthanum carbonate
-
Sprague SM. A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate. Curr Med Res Opin 2007; 23: 3167-3175
-
(2007)
Curr Med Res Opin
, vol.23
, pp. 3167-3175
-
-
Sprague, S.M.1
-
54
-
-
84965145158
-
Phosphate binders and clinical outcomes in stage 5D CKD patients
-
in press
-
Zoccali A, Mallamaci F, Cannata-Andía JB. Phosphate binders and clinical outcomes in stage 5D CKD patients. Sem Dialysis 2015 (in press)
-
(2015)
Sem Dialysis
-
-
Zoccali, A.1
Mallamaci, F.2
Cannata-Andía, J.B.3
-
55
-
-
84891559221
-
AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a singledose study in hemodialysis patients
-
Martin KJ, Pickthorn K, Huang S et al. AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a singledose study in hemodialysis patients. Kidney Int 2014; 85: 191-197
-
(2014)
Kidney Int
, vol.85
, pp. 191-197
-
-
Martin, K.J.1
Pickthorn, K.2
Huang, S.3
-
56
-
-
84965109108
-
Tratamiento de la hiperfosforemia: Papel de los captores de fósforo
-
Cannata-Andía JB, (ed). Barcelona: Wolters Kluwer Health España, S.A
-
Cannata Andía JB, Frazao J, Ferreira A et al. Tratamiento de la hiperfosforemia: papel de los captores de fósforo. In: Cannata-Andía JB, (ed). Alteraciones del metabolismo óseo y mineral en la enfermedd renal crónica: avances en patogenia, diagnóstico y tratamiento. Barcelona: Wolters Kluwer Health España, S.A., 2010, pp. 197-208
-
(2010)
Alteraciones Del Metabolismo ?seo y Mineral en la Enfermedd Renal Crónica: Avances en Patogenia, Diagnóstico y Tratamiento
, pp. 197-208
-
-
Cannata Andía, J.B.1
Frazao, J.2
Ferreira, A.3
|